To amend title XVIII of the Social Security Act to exempt certain drugs from the part D manufacturer discount program under the Medicare program.
See how your representatives voted on this bill.
DeepSyte matches this bill to the issues you care about and shows whether your reps' votes line up — not party, not press releases. Take the 2-minute values quiz to see your alignment.
Alignment with your views
Sign in and take the values quiz to see how this bill lines up with what you've said.
Summary
This bill amends the Medicare Part D manufacturer discount program to exempt certain orally administered drugs from the discount requirements. Specifically, it excludes drugs that received FDA approval through a new drug application and have been granted a narrow exception to be reclassified as noninnovator multiple source drugs under the Medicaid drug rebate program.
Values analysis
Sign in and take the values quiz to get a personalized read on how this bill lines up with your positions.
How your representatives voted
Sign in to see how your representatives voted on this bill.